Tenax Therapeutics (NASDAQ:TENX) Earns Buy Rating from Analysts at Guggenheim
Guggenheim started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a research report report published on Monday, MarketBeat reports. The firm issued a buy rating and a $16.00 price target on the specialty pharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the stock. William Blair began […]
More Stories
Is A Man on the Inside Season 3 Confirmed? Everything We Know So Far
Upon the completion of Season 2 of the series A Man on the Inside, people started asking for the series’...
Top 10 Hottest Female Rappers in the World in 2026
Are you also interested in knowing who is the hottest and sexiest rapper in 2026 and where most of them...
Asking Rents Decline in November: Zillow
By Naveen Athrappully Home rents across the United States edged down in November, in line with a slowdown usually seen...
US Department of State Issues Travel Advisory Against 2 Middle Eastern Countries
By Naveen Athrappully The U.S. Department of State renewed its travel advisory for two Middle Eastern nations—Yemen and Jordan—last week...
Paramount Updates Warner Bros. Offer, Affirms Ellison Family Backing
By Andrew Moran Paramount Skydance amended its offer to buy Warner Bros. Discovery on Dec. 22, guaranteeing backing from Oracle...
Japan to Resume Operations at World’s Largest Nuclear Plant 15 Years After Fukushima Disaster
By Rachel Roberts Japan is set to resume operations at the world’s largest nuclear power plant, marking a key development...